Without A Prescription |
| ||
|
OTRIVIN Natru Vent |
|
| ||
Home » Prescription Drugs 12 » OTRIVIN Natru Vent Otrivine nasal spray contains the active ingredient xylometazoline which is a type of medicine called a decongestant. When this medicine is administered into the nose the xylometazoline works by acting on alpha receptors that are found in the walls of blood vessels in the linings of the nasal passages and sinuses. It causes these blood vessels to contract and narrow thereby decreasing blood flow into the linings of the nose and sinuses. This reduces swelling and the feeling of congestion. It also reduces the production of mucus helping to relieve a blocked nose. The nasal spray helps relieve congestion in a few minutes and the effect of the medicine lasts for up to 10 hours. As the medicine causes the blood vessels in the nose to contract it minimises the amount of medicine that is absorbed into the bloodstream from the nose. This means that the nasal drops have a relatively local effect in the nose and are unlikely to have side effects on other parts of the body. What is it used for? Relieving a blocked nose (nasal congestion) associated with colds flu sinusitis and nasal allergies (allergic rhinitis) such as hayfever. Buy OTRIVIN Natru Vent and other Prescription Drugs 12 products online at Medstore. 875
About OTRIVIN Natru Vent: Product Type: Prescription Drugs 12 OTRIVIN ( Natru-Vent Generic Xylometazoline ) OTRIVIN (Natru-Vent Generic Xylometazoline) Natru-Vent Generic Xylometazoline 0.1% w/v 10ml Spray Natru-Vent Generic Xylometazoline OTRIVIN
View more Prescription Drugs 12 Without A Prescription: Education on antibiotic prescribing in Quebec worked. Guidelines for Quebec doctors on proper antibiotic use led to a decline in these prescriptions in the province, while prescribing rose in other provinces, a new study suggests. The guidelines were published and disseminated to Quebec doctors and pharmacists in January 2005 due to worries about the overuse of antibiotics and partly as a response to an outbreak of Clostridium difficile infections. Antibiotic consumption per capita was already 23.3 per cent higher in Canada generally than in Quebec in 2004, the study showed. But in the year that followed publication of the guidelines, the number of outpatient antibiotic prescriptions in Quebec decreased 4.2 per cent, the study said, while increasing 6.5 per cent in other Canadian provinces. The trend persisted three years later.
| ||
